Manikay Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Manikay Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-775,000	Closed	-$14.6M	–	34
2019 Q3	$14.6M	Buy	+775,000	New	+$8.86M	1.52%	16

Manikay Partners's ALDR Position: Q4 2019 in Review

Manikay Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 775,000 shares — an estimated $14.6M sold.

Manikay Partners first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $14.6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Manikay Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Manikay Partners sold 775,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $14.6M.
Manikay Partners first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Manikay Partners's Alder Biopharmaceuticals position peaked at $14.6M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Manikay Partners's 13F filing for Q4 2019, filed 14 Feb 2020.